Jane Gonnerman - Horizon Pharma Office Staff

Insider

Jane Gonnerman is Office Staff of Horizon Pharma PLC
Phone353 1 772 2100
Webhttps://www.horizontherapeutics.com

Horizon Pharma Management Efficiency

The company has return on total asset (ROA) of 0.0444 % which means that it generated a profit of $0.0444 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0854 %, meaning that it created $0.0854 on every $100 dollars invested by stockholders. Horizon Pharma's management efficiency ratios could be used to measure how well Horizon Pharma manages its routine affairs as well as how well it operates its assets and liabilities.
Horizon Pharma PLC currently holds 2.56 B in liabilities with Debt to Equity (D/E) ratio of 0.53, which is about average as compared to similar companies. Horizon Pharma PLC has a current ratio of 3.88, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Horizon Pharma's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Jennifer MauerMerck Company
N/A
Paul PenepentNovartis AG ADR
N/A
Mathai MammenJohnson Johnson
53
Thomas SchineckerRoche Holding Ltd
48
Eva SchaeferJansenSanofi ADR
N/A
Laurent GilhodesSanofi ADR
N/A
BCH BMBristol Myers Squibb
57
Samir MDNovartis AG ADR
62
Karen HaleNovartis AG ADR
57
Derica RiceBristol Myers Squibb
56
Johannes MDRoche Holding Ltd
66
Deborah EldracherAstraZeneca PLC ADR
59
Sally JacksonGlaxoSmithKline PLC ADR
52
Josep CatllaSanofi ADR
N/A
Aradhana MDAstraZeneca PLC ADR
51
Linda LouieAmgen Inc
N/A
A WashingtonJohnson Johnson
70
Michelle WeeseBristol Myers Squibb
50
Michael MasonEli Lilly and
54
Elaine SorgAbbVie Inc
54
Alonzo WeemsEli Lilly and
54
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland with additional offices in Deerfield, Illinois Chicago, Illinois Lake Forest, Illinois South San Francisco, California Washington, D.C. Gaithersburg, Maryland Rockville, Maryland and Mannheim, Germany. Horizon Therapeutics is traded on NASDAQ Exchange in the United States. Horizon Pharma PLC (HZNP) is traded on NASDAQ Exchange in USA and employs 2,190 people.

Management Performance

Horizon Pharma PLC Leadership Team

Elected by the shareholders, the Horizon Pharma's board of directors comprises two types of representatives: Horizon Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Horizon. The board's role is to monitor Horizon Pharma's management team and ensure that shareholders' interests are well served. Horizon Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Horizon Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jane Gonnerman, Office Staff
Sean JD, Exec Counsel
Timothy Walbert, Chairman, CEO and Pres
Tina Ventura, Senior Vice President Investor Relations
Patrick McIlvenny, VP Officer
Paul Hoelscher, CFO and Executive VP of Fin.
FACP FACP, Ex Officer
Andy Pasternak, Ex Officer
Aaron Cox, Exec CFO
Geoffrey Curtis, Senior Vice President - Corporate Communications

Horizon Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Horizon Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Horizon Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Horizon Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Horizon Pharma will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Kimberly Clark could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kimberly Clark when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kimberly Clark - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kimberly Clark to buy it.
The correlation of Kimberly Clark is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kimberly Clark moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kimberly Clark moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kimberly Clark can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Horizon Stock

If you are still planning to invest in Horizon Pharma PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Horizon Pharma's history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios